ArticleTherapeutics and clinical risk management2018

What is known about deferasirox chelation therapy in pediatric HSCT recipients: two case reports of metabolic acidosis.

Carmen Fucile et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.